Bashir, Q., Khan, H., Thall, P. F., Liu, P., Shah, N., Kebriaei, P., . . . Qazilbash, M. (2013). A Randomized Phase II Trial of Fludarabine/Melphalan 100 versus Fludarabine/Melphalan 140 followed by Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Multiple Myeloma.
Style de citation ChicagoBashir, Qaiser, et al. A Randomized Phase II Trial of Fludarabine/Melphalan 100 Versus Fludarabine/Melphalan 140 Followed By Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Multiple Myeloma. 2013.
Style de citation MLABashir, Qaiser, et al. A Randomized Phase II Trial of Fludarabine/Melphalan 100 Versus Fludarabine/Melphalan 140 Followed By Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Multiple Myeloma. 2013.